ES2100222T3 - Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas. - Google Patents

Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas.

Info

Publication number
ES2100222T3
ES2100222T3 ES91810580T ES91810580T ES2100222T3 ES 2100222 T3 ES2100222 T3 ES 2100222T3 ES 91810580 T ES91810580 T ES 91810580T ES 91810580 T ES91810580 T ES 91810580T ES 2100222 T3 ES2100222 T3 ES 2100222T3
Authority
ES
Spain
Prior art keywords
aminoalcansulfonico
derivatives
acid
prevent
pharmaceutical compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91810580T
Other languages
English (en)
Inventor
Kunihiko Higashiura
Kazuharu Ienaga
Masao Hattori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2192575A external-priority patent/JP3070687B2/ja
Priority claimed from JP2223807A external-priority patent/JP3068841B2/ja
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2100222T3 publication Critical patent/ES2100222T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION ESTA RELACIONADA CON UN COMPUESTO FARMACEUTICO PARA SU USO EN LA PREVENCION O TRATAMIENTO DE ENFERMEDADES DEL CORAZON EN UN MAMIFERO, QUE COMPRENDA AL MENOS UN DERIVADO DE ACIDO AMINOALCANOSULFONICO DE LA FORMULA (I): EN LA QUE X ES HIDROGENO O UN RESIDUO DE AMINOACIDO; Y ES HIDROGENO, UN GRUPO FENIL O UN GRUPO ALQUILO, QUE PUEDEN TENER UN GRUPO HIDROXIDO, AMINO, CARBOXIDO, FENIL O HIDROXIFENIL; O X E Y SE UNEN PARA FORMAR UN GRUPO TRIMETILENO O HIDROXITRIMETILENO; Y AL MENOS UNO DE X E Y ES DISTINTO DEL HIDROGENO; O SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO.
ES91810580T 1990-07-19 1991-07-18 Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas. Expired - Lifetime ES2100222T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2192575A JP3070687B2 (ja) 1990-07-19 1990-07-19 心疾患治療剤
JP2223807A JP3068841B2 (ja) 1990-08-23 1990-08-23 アミノアルカンスルホン酸誘導体を有効成分として含有する心疾患治療剤

Publications (1)

Publication Number Publication Date
ES2100222T3 true ES2100222T3 (es) 1997-06-16

Family

ID=26507401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91810580T Expired - Lifetime ES2100222T3 (es) 1990-07-19 1991-07-18 Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas.

Country Status (5)

Country Link
US (1) US5430052A (es)
EP (1) EP0467856B1 (es)
AT (1) ATE150301T1 (es)
DE (1) DE69125216T2 (es)
ES (1) ES2100222T3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US6007819A (en) * 1995-10-17 1999-12-28 Dovetail Technologies, Inc. Methods of inducing immunity using low molecular weight immune stimulants
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
JP2005531506A (ja) 2002-03-01 2005-10-20 メルク　エンド　カムパニー　インコーポレーテッド Ｅｄｇ受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
US6774261B2 (en) * 2002-08-29 2004-08-10 Buffers & Biochemicals Corporation High purity amino-organosulfonic acid zwitterionic compositions
MXPA05013975A (es) * 2003-06-23 2006-03-09 Neurochem Int Ltd Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
MX2008008213A (es) * 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
US20070261933A1 (en) * 2006-04-26 2007-11-15 Scott C W Conveyor roller assembly and conveyor roller insert
KR101608445B1 (ko) 2006-10-12 2016-04-01 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
EP2120905A1 (en) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
CA2733390A1 (en) * 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
FR2961392A1 (fr) * 2010-06-17 2011-12-23 Oreal Utilisation de derives d'acide amine comme agent de traitement de la transpiration humaine ; nouveaux composes ; compositions les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3189M (fr) * 1963-07-13 1965-03-15 Pharmaco Biolog Soc Médicament a base d'acide 2-amino-éthanesulfonique.
NL6708311A (es) * 1966-06-18 1967-12-19
JPS494210B1 (es) * 1970-06-17 1974-01-31
CH665645A5 (fr) * 1981-07-09 1988-05-31 Michel Flork Derives de dipeptides et leur procede de preparation.
US5011983A (en) * 1987-01-23 1991-04-30 Minnesota Mining And Manufacturing Company Preparation and reactions of omega-halosulfonyl perfluoroalkanesulfonates

Also Published As

Publication number Publication date
US5430052A (en) 1995-07-04
EP0467856A3 (en) 1992-10-14
DE69125216T2 (de) 1997-09-25
EP0467856B1 (en) 1997-03-19
ATE150301T1 (de) 1997-04-15
DE69125216D1 (de) 1997-04-24
EP0467856A2 (en) 1992-01-22

Similar Documents

Publication Publication Date Title
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
NO890723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
PT723540E (pt) Compostos triciclicos de amida e ureia uteis para inibicao da funcao da g-proteina e para o tratamento de doencas proliferativas.
EP0371559A3 (en) Use of benzimidazoles in the treatment of epithelial disorders
BR9807950A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto
PT734259E (pt) Utilizacao de derivados de piperidina para o tratamento da esquizofrenia
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
FI102964B1 (fi) Terapeuttisia yhdisteitä
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
HUT66515A (en) Process for preparing piperidine derivatives and pharmaceutical compositions contg. them as active ingredients
ES538847A0 (es) Un derivado de fenilserina
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
BR9910628A (pt) Uso de um composto da série da benzofuroxana, composição farmacêutica, e, processos para a preparação de uma formulação parenteral e para o tratamento de um mamìfero, incluindo um ser humano, de doenças cardìacas da coronária
FR2549049B1 (fr) Nouvelles amidines, leur procede de preparation et leur application therapeutique
ATE169217T1 (de) Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten
BR0317289A (pt) Método para tratar distúrbios do movimento usando derivados do ácido barbitúrico
PT92047A (pt) Processo para a preparacao de derivados de nitroxialquilaminas com a funcao amida, de compostos intermediarios e de composicoes farmaceuticas que as contem
NO923198L (no) Terapeutiske midler
ES8603406A1 (es) Un procedimiento para producir derivados de acilindol
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
BR9813775A (pt) Uso de um composto, processo para o tratamento de uma condição de cefaléia vascular, e, composição farmacêutica adequada para uso no tratamento de uma condição de cefaléia vascular.
NZ216110A (en) 4-(z)-6-((2,4,5-cis -2-alkyl-4-(2-hydroxyphenyl)-1,3- dioxan-5-yl) hexenoic acid derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 467856

Country of ref document: ES